Literature DB >> 2830961

Translocation breakpoint in t(11;14) in B-cell leukemia is not at the rare fragile site at 11q13.3.

A H Puspurs1, E Baker, D F Callen, A Fratini, G R Sutherland.   

Abstract

The cloned breakpoint at 11q13.3 of the t(11;14)(q13.3;q32.3) in a B-cell lymphocytic leukemia (B-CLL) was used to analyze DNA from individuals with and without the rare folate-sensitive fragile site at 11q13.3. On Southern blots there were no discernible differences. Subclones of the ends of the leukemia breakpoint clone were prepared and used for in situ hybridization to chromosomes expressing fra(11)(q13.3). Both subclones hybridized distal to the fragile site. These experiments indicate that the breakpoints at 11q13.3 in B-CLL (and in a B-cell lymphoma) are not at the fragile site at 11q13.3.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2830961     DOI: 10.1016/0165-4608(88)90006-4

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  2 in total

1.  Cancer in relatives of leukemic patients with chromosomal rearrangements at rare (heritable) fragile-site locations in their malignant cells.

Authors:  E H Mules; J R Testa; G H Thomas; H Abbey; B H Cohen
Journal:  Am J Hum Genet       Date:  1989-06       Impact factor: 11.025

2.  A new rare distamycin A-inducible fragile site, fra(11) (p15.1), found in two acute nonlymphocytic leukemia (ANLL) patients with t(7;11)(p15-p13;p15).

Authors:  E Takahashi; Y Kaneko; T Ishihara; M Minamihisamatsu; M Murata; T Hori
Journal:  Hum Genet       Date:  1988-10       Impact factor: 4.132

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.